{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:14:28Z","timestamp":1779916468283,"version":"3.53.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100019971","name":"Luzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2021LZXNYD-J23"],"award-info":[{"award-number":["2021LZXNYD-J23"]}],"id":[{"id":"10.13039\/501100019971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2022YFS0608"],"award-info":[{"award-number":["2022YFS0608"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20384"],"award-info":[{"award-number":["U20A20384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11307-025-02036-x","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T13:46:41Z","timestamp":1753537601000},"page":"764-773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and Evaluation of a Vinyl Sulfone-Based Fluorine-18 Labeling Method for Constructing PSMA-targeted Prostate Cancer Imaging Agents"],"prefix":"10.1007","volume":"27","author":[{"given":"Changjiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0284-5958","authenticated-orcid":false,"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"issue":"5","key":"2036_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.juro.2015.12.025","volume":"195","author":"T Maurer","year":"2016","unstructured":"Maurer T, Gschwend JE, Rauscher I et al (2016) Diagnostic efficacy of (68)gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer. J Urol 195(5):1436\u20131443. https:\/\/doi.org\/10.1016\/j.juro.2015.12.025","journal-title":"J Urol"},{"issue":"3","key":"2036_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2967\/jnumed.118.212233","volume":"60","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Knorr K, Spohn F et al (2019) Detection efficacy of 18F-PSMA-1007 PET\/CT in 251 patients with biochemical recurrence of prostate cancer after radical prostatectomy. J Nucl Med 60(3):362\u2013368. https:\/\/doi.org\/10.2967\/jnumed.118.212233","journal-title":"J Nucl Med"},{"issue":"17","key":"2036_CR3","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.19.02757","volume":"38","author":"EJ Trabulsi","year":"2020","unstructured":"Trabulsi EJ, Rumble RB, Jadvar H et al (2020) Optimum imaging strategies for advanced prostate cancer: ASCO guideline. J Clin Oncol 38(17):1963\u20131996. https:\/\/doi.org\/10.1200\/JCO.19.02757","journal-title":"J Clin Oncol"},{"issue":"8","key":"2036_CR4","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.3390\/cancers12082153","volume":"12","author":"S Annunziata","year":"2020","unstructured":"Annunziata S, Pizzuto DA, Treglia G (2020) Diagnostic performance of PET imaging using different radiopharmaceuticals in prostate cancer according to published meta-analyses. Cancers (Basel) 12(8):2153. https:\/\/doi.org\/10.3390\/cancers12082153","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2036_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13550-020-00635-z","volume":"10","author":"P Werner","year":"2020","unstructured":"Werner P, Neumann C, Eiber M et al (2020) (2020) [99cmTc]Tc-PSMA-I&S-SPECT\/CT: experience in prostate cancer imaging in an outpatient center. EJNMMI Res 10(1):45. https:\/\/doi.org\/10.1186\/s13550-020-00635-z","journal-title":"EJNMMI Res"},{"issue":"1","key":"2036_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijrobp.2021.03.055","volume":"111","author":"SC Masters","year":"2021","unstructured":"Masters SC, Hofling AA, Gorovets A et al (2021) FDA approves Ga 68 PSMA-11 for prostate cancer imaging. Int J Radiat Oncol Biol Phys 111(1):27\u201328. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.03.055","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2036_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11864-022-00967-z","volume":"23","author":"E Fortunati","year":"2022","unstructured":"Fortunati E, Argalia G, Zanoni L et al (2022) New PET radiotracers for the imaging of neuroendocrine neoplasms. Curr Treat Options Oncol 23(5):703\u2013720. https:\/\/doi.org\/10.1007\/s11864-022-00967-z","journal-title":"Curr Treat Options Oncol"},{"issue":"9","key":"2036_CR8","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1007\/s00259-021-05210-9","volume":"48","author":"IL Alberts","year":"2021","unstructured":"Alberts IL, Seide SE, Mingels C et al (2021) Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis. Eur J Nucl Med Mol Imaging 48(9):2978\u20132989. https:\/\/doi.org\/10.1007\/s00259-021-05210-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"2036_CR9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2174\/1568026611313080008","volume":"13","author":"RC Mease","year":"2013","unstructured":"Mease RC, Foss CA, Pomper MG (2013) PET imaging in prostate cancer: focus on prostate-specific membrane antigen. Curr Top Med Chem 13(8):951\u2013962. https:\/\/doi.org\/10.2174\/1568026611313080008","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"2036_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/thno.37894","volume":"10","author":"RA Werner","year":"2020","unstructured":"Werner RA, Derlin T, Lapa C et al (2020) 18F-Labeled, PSMA-targeted radiotracers: leveraging the advantages of radiofluorination for prostate cancer molecular imaging. Theranostics 10(1):1\u201316. https:\/\/doi.org\/10.7150\/thno.37894","journal-title":"Theranostics"},{"issue":"10","key":"2036_CR11","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1158\/1078-0432.CCR-07-1517","volume":"14","author":"RC Mease","year":"2008","unstructured":"Mease RC, Dusich CL, Foss CA et al (2008) N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4 [18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer. Clin Cancer Res 14(10):3036\u20133043. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-1517","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2036_CR12","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","volume":"44","author":"FL Giesel","year":"2017","unstructured":"Giesel FL, Hadaschik B, Cardinale J et al (2017) (2017) F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients. Eur J Nucl Med Mol Imaging 44(4):678\u201388. https:\/\/doi.org\/10.1007\/s00259-016-3573-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"2036_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11307-015-0850-8","volume":"17","author":"Z Szabo","year":"2015","unstructured":"Szabo Z, Mena E, Rowe SP et al (2015) Initial evaluation of [(18)F]DCFPyL for prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer. Mol Imaging Biol 17(4):565\u2013574. https:\/\/doi.org\/10.1007\/s11307-015-0850-8","journal-title":"Mol Imaging Biol"},{"issue":"7","key":"2036_CR14","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.2967\/jnumed.114.137489","volume":"55","author":"Z Wu","year":"2014","unstructured":"Wu Z, Li L, Liu S et al (2014) Facile preparation of a thiol-reactive (18)F-labeling agent and synthesis of (18)F-DEG-VS-NT for PET imaging of a neurotensin receptor-positive tumor. J Nucl Med 55(7):1178\u20131184. https:\/\/doi.org\/10.2967\/jnumed.114.137489","journal-title":"J Nucl Med"},{"issue":"11","key":"2036_CR15","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1021\/acs.bioconjchem.0c00487","volume":"31","author":"T Zhang","year":"2020","unstructured":"Zhang T, Cai J, Wang H et al (2020) RXH-Reactive 18F-vinyl sulfones as versatile agents for PET probe construction. Bioconjug Chem 31(11):2482\u20132487. https:\/\/doi.org\/10.1021\/acs.bioconjchem.0c00487","journal-title":"Bioconjug Chem"},{"issue":"2","key":"2036_CR16","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1021\/acs.molpharmaceut.1c00743","volume":"19","author":"T Zhang","year":"2022","unstructured":"Zhang T, Cai J, Xu M et al (2022) Development of 18F-labeled vinyl sulfone-PSMAi conjugates as new PET agents for prostate cancer imaging. Mol Pharm 19(2):720\u2013727. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.1c00743","journal-title":"Mol Pharm"},{"key":"2036_CR17","doi-asserted-by":"crossref","unstructured":"Ma G, McDaniel WJ, Murphy JM (2020) One-step synthesis of [18F] fluoro-4-(vinyl sulfonyl)benzene: a thiol reactive synthon for selective radio fluorination of peptides. Org Lett 23:530\u2212534.\u00a0https:\/\/pubs.acs.org\/doi\/10.1021\/acs.orglett.0c04054","DOI":"10.1021\/acs.orglett.0c04054"},{"key":"2036_CR18","doi-asserted-by":"publisher","first-page":"108311","DOI":"10.1016\/j.nucmedbio.2022.108311","volume":"116\u2013117","author":"M Hu","year":"2023","unstructured":"Hu M, Yang L, Liu N et al (2023) Evaluation of sulfone-labeled amino acid derivatives as potential PET agents for cancer imaging. Nucl Med Biol 116\u2013117:108311. https:\/\/doi.org\/10.1016\/j.nucmedbio.2022.108311","journal-title":"Nucl Med Biol"},{"key":"2036_CR19","doi-asserted-by":"publisher","unstructured":"Sen S, Young J, Berrisford JM, et al (2014) Small molecule annotation for the Protein Data Bank. Database. 2014 https:\/\/doi.org\/10.1093\/database\/bau116","DOI":"10.1093\/database\/bau116"},{"issue":"1","key":"2036_CR20","doi-asserted-by":"publisher","first-page":"19122","DOI":"10.1038\/s41598-021-98555-y","volume":"11","author":"H Chen","year":"2021","unstructured":"Chen H, Cai P, Feng Y et al (2021) In vitro and in vivo comparative study of a novel 68Ga-labeled PSMA-targeted inhibitor and 68Ga-PSMA-11. Sci Rep 11(1):19122. https:\/\/doi.org\/10.1038\/s41598-021-98555-y","journal-title":"Sci Rep"},{"issue":"16","key":"2036_CR21","doi-asserted-by":"publisher","first-page":"22531","DOI":"10.18632\/oncotarget.8001","volume":"7","author":"M Michalska","year":"2016","unstructured":"Michalska M, Schultze-Seemann S, Bogatyreva L, Hauschke D, Wetterauer U, Wolf P (2016) In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer. Oncotarget 7(16):22531. https:\/\/doi.org\/10.18632\/oncotarget.8001","journal-title":"Oncotarget"},{"key":"2036_CR22","doi-asserted-by":"publisher","first-page":"114138","DOI":"10.1016\/j.ejmech.2022.114138","volume":"232","author":"DJ Modemann","year":"2022","unstructured":"Modemann DJ, Mahardhika AB, Yamoune S et al (2022) Development of high-affinity fluorinated ligands for cannabinoid subtype 2 receptor, and in vitro evaluation of a radioactive tracer for imaging. Eur J Med Chem 232:114138. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114138","journal-title":"Eur J Med Chem"},{"issue":"14","key":"2036_CR23","doi-asserted-by":"publisher","first-page":"7431","DOI":"10.3390\/ijms22147431","volume":"22","author":"M Staniszewska","year":"2021","unstructured":"Staniszewska M, Fragoso Costa P, Eiber M et al (2021) Enzalutamide enhances PSMA expression of PSMA-low prostate cancer. Int J Mol Sci 22(14):7431. https:\/\/doi.org\/10.3390\/ijms22147431","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2036_CR24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2967\/jnumed.119.232603","volume":"61","author":"N Ramos","year":"2020","unstructured":"Ramos N, Baquero-Buitrago J, Ben Youss Gironda Z et al (2020) Noninvasive PET imaging of CDK4\/6 activation in breast cancer. J Nucl Med 61(3):437\u2013442. https:\/\/doi.org\/10.2967\/jnumed.119.232603","journal-title":"J Nucl Med"},{"issue":"2","key":"2036_CR25","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1021\/acs.molpharmaceut.2c01101","volume":"20","author":"P Cai","year":"2023","unstructured":"Cai P, Tang S, Xia L et al (2023) Improve the biodistribution with bulky and lipophilic modification strategies on lys-urea-glu-based PSMA-targeting radiotracers. Mol Pharm 20(2):1435\u20131446. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c01101","journal-title":"Mol Pharm"},{"key":"2036_CR26","doi-asserted-by":"publisher","first-page":"889737","DOI":"10.3389\/fchem.2022.889737","volume":"10","author":"M Kre\u010dmerov\u00e1","year":"2022","unstructured":"Kre\u010dmerov\u00e1 M, Majer P, Rais R et al (2022) Phosphonates and phosphonate prodrugs in medicinal chemistry: Past successes and future prospects. Front Chem 10:889737. https:\/\/doi.org\/10.3389\/fchem.2022.889737","journal-title":"Front Chem"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02036-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-025-02036-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02036-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:29:50Z","timestamp":1763404190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-025-02036-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2036"],"URL":"https:\/\/doi.org\/10.1007\/s11307-025-02036-x","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"28 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study protocol was approved by the Institutional Review Board of The Affiliated Hospital of Southwest Medical University Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}